The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
A transcriptional switch governs fibroblast activation in heart disease
Open accessPublished version of a preprint
Abstract
In diseased organs, stress-activated signalling cascades alter chromatin, thereby triggering maladaptive cell state transitions. Fibroblast activation is a common stress response in tissues that worsens lung, liver, kidney and heart disease, yet its mechanistic basis remains unclear 1,2. Pharmacological inhibition of bromodomain and extra-terminal domain (BET) proteins alleviates cardiac dysfunction 3-7, providing a tool to interrogate and modulate cardiac cell states as a potential therapeutic approach. Here we use single-cell epigenomic analyses of hearts dynamically exposed to BET inhibitors to reveal a reversible transcriptional switch that underlies the activation of fibroblasts. Resident cardiac fibroblasts demonstrated robust toggling between the quiescent and activated state in a manner directly correlating with BET inhibitor exposure and cardiac function. Single-cell chromatin accessibility revealed previously undescribed DNA elements, the accessibility of which dynamically correlated with cardiac performance. Among the most dynamic elements was an enhancer that regulated the transcription factor MEOX1, which was specifically expressed in activated fibroblasts, occupied putative regulatory elements of a broad fibrotic gene program and was required for TGFβ-induced fibroblast activation. Selective CRISPR inhibition of the single most dynamic cis-element within the enhancer blocked TGFβ-induced Meox1 activation. We identify MEOX1 as a central regulator of fibroblast activation associated with cardiac dysfunction and demonstrate its upregulation after activation of human lung, liver and kidney fibroblasts. The plasticity and specificity of BET-dependent regulation of MEOX1 in tissue fibroblasts provide previously unknown trans- and cis-targets for treating fibrotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As expected4, fibroblasts had the highest enrichment of genes whose expression significantly correlated with cardiac function (Fig. 1E).”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The possibility that JQ1 treatment can reversibly direct fibroblast activation away from the FAP/POSTN cell state indicates the therapeutic potential of targeting the differentiation and maturation of FAP+ fibroblasts28,30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BET inhibition exerted a strong protective effect on left ventricular ejection fraction (Fig. 1B)4,6-10.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“We previously showed the specific importance of BRD4 in aspects of heart failure pathogenesis4,25.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Given our observation that transcriptional changes associated with JQ1 in the cardiomyocyte (CM) compartment are modest compared to other cardiac cell populations4,11”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“RNA-seq and DE analysis among fibroblasts identified a small group of genes that were sensitive to TGFB stimulation and had increased expression when TGFB and IL1B were used in combination (Fig. 5B). These included genes such as SERPINA9, EGR2, LRRC152 and MEOX1, a critical transcriptional regulator of cardiac fibroblast activation.4.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Motif analysis of these regions revealed enrichment for TFs critical for profibrotic responses in heart failure, such as SMADs27 and MEOX14, as well as RUNX1 and REL, regulators of proinflammatory responses27 (Extended Data Fig. 4D).”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“We previously demonstrated that pharmacological inhibition of bromodomain and extra-terminal domain (BET) proteins, critical mediators of stress-activated chromatin signaling in various diseases3, modulates a reversible transcriptional switch that governs fibroblast activation in chronic heart failure through the transcription factor (TF) MEOX14.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“As our previous work demonstrated that Meox1 transcription is sensitive to BET inhibition4, which we confirmed in human cardiac fibroblasts treated with IL1B and TGFB (Extended Data Fig. 9Q)”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“We found reductions in chromatin accessibility at the Postn and Meox1 loci in TAC-Brd4KO fibroblasts, including regulatory elements we previously showed were essential for stress-induced activation of those genes (Fig. 3Q, regions highlighted in red)4.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Within the human MEOX1 locus, we found that the region associated with strong enrichment of H3K27Ac was the syntenic element of the mouse stress-dependent Meox1 Peak9/10 enhancer4 (Fig. 5D).”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“a critical regulator of the stress-activated fibroblast response4”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“MEOX1 was previously implicated in cardiac fibrosis28.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, previous and concurrent work has highlighted the functional role of this gene regulatory network in cardiac fibrosis28–30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Self-citationDimensionality reduction for visualizing single-cell data using UMAP
Becht, E., McInnes, L., Healy, J., Dutertre, C.-A., Kwok, I. W. H., Ng, L. G., Ginhoux, F., & Newell, E. W. (2019) · Nature Biotechnology · doi:10.1038/nbt.4314 · Cited by 5,358
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Cited by
Sorted by citations
Spatial multi-omic map of human myocardial infarction
Kuppe, C., Ramirez Flores, R. O., Li, Z., Hayat, S., Levinson, R. T., Liao, X., Hannani, M. T., Tanevski, J., Wünnemann, F., Nagai, J. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05060-x · Cited by 772
Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure
Koenig, A. L., Shchukina, I., Amrute, J., Andhey, P. S., Zaitsev, K., Lai, L., Bajpai, G., Bredemeyer, A., Smith, G., Jones, C., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00028-6 · Cited by 482
Targeting immune–fibroblast cell communication in heart failure
Amrute, J. M., Luo, X., Penna, V., Yang, S., Yamawaki, T., Hayat, S., Bredemeyer, A., Jung, I.-H., Kadyrov, F. F., Heo, G. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08008-5 · Cited by 339
Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction
Janbandhu, V. C., Tallapragada, V. J., Patrick, R., Li, Y., Abeygunawardena, D., Humphreys, D. T., Martin, E. M. M. A., Ward, A. O., Contreras, O., Farbehi, N., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.10.009 · Cited by 230
Therapeutic targets for cardiac fibrosis: from old school to next-gen
Travers, J. G., Tharp, C. A., Rubino, M., & McKinsey, T. A. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148554 · Cited by 179
Self-citationTani, H., Sadahiro, T., Yamada, Y., Isomi, M., Yamakawa, H., Fujita, R., Abe, Y., Akiyama, T., Nakano, K., Kuze, Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058655 · Cited by 149
Ravassa, S., López, B., Treibel, T. A., José, G. S., Losada-Fuentenebro, B., Tapia, L., Bayés‐Genís, A., Díez, J., & González, A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101194 · Cited by 139
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Pelonero, A., Lee, C. Y., Sadagopan, N., Huang, Y., Auclair, K., et al. (2024) · Nature · doi:10.1038/s41586-024-08085-6 · Cited by 140
Self-citationSingle-cell transcriptomics for the assessment of cardiac disease
Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Ghazal, R., Wang, M., Liu, D., Tschumperlin, D. J., & Pereira, N. L. (2025) · Circulation Research · doi:10.1161/circresaha.124.325402 · Cited by 128
Alvisi, G., Termanini, A., Soldani, C., Portale, F., Carriero, R., Pilipow, K., Costa, G., Polidoro, M. A., Franceschini, B., Malenica, I., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.043 · Cited by 114
Mapping the cardiac vascular niche in heart failure
Peisker, F., Halder, M., Nagai, J. S., Ziegler, S. M., Kaesler, N., Hoeft, K., Li, R., Bindels, E. M., Kuppe, C., Moellmann, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30682-0 · Cited by 103
Liu, X., Yin, K., Chen, L., Chen, W., Li, W., Zhang, T., Sun, Y., Yuan, M., Wang, H., Song, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00490-3 · Cited by 100
Genetics of myocardial interstitial fibrosis in the human heart and association with disease
Nauffal, V., Achille, P. D., Klarqvist, M. D. R., Cunningham, J. W., Hill, M. C., Pirruccello, J. P., Weng, L.-C. C., Morrill, V. N., Choi, S. H., Khurshid, S. S., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01371-5 · Cited by 96
Allanki, S., Strilić, B., Scheinberger, L., Onderwater, Y. L., Marks, A., Günther, S., Preussner, J., Kikhi, K., Looso, M., Stainier, D. Y. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6497 · Cited by 84
Patrick, R., Janbandhu, V. C., Tallapragada, V. J., Tan, S. S. M., McKinna, E. E., Contreras, O., Ghazanfar, S., Humphreys, D. T., Murray, N. J., Tran, T. H. Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk8501 · Cited by 96
Transcription factor protein interactomes reveal genetic determinants in heart disease
González‐Terán, B., Pittman, M., Felix, F., Thomas, R., Richmond-Buccola, D., Hüttenhain, R., Choudhary, K., Moroni, E., Costa, M. W., Huang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.021 · Cited by 83
Self-citationDefining cardiac functional recovery in end-stage heart failure at single-cell resolution
Amrute, J. M., Lai, L., Ma, P., Koenig, A. L., Kamimoto, K., Bredemeyer, A., Shankar, T. S., Kuppe, C., Kadyrov, F. F., Schulte, L. J., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00260-8 · Cited by 79
McKinsey, T. A., Foo, R., Anene-Nzelu, C. G., Travers, J. G., Vagnozzi, R. J., Weber, N., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac142 · Cited by 84
Self-citationBRD4 in physiology and pathology: ‘‘BET’’ on its partners
Liang, Y., Tian, J., & Wu, T. (2021) · BioEssays · doi:10.1002/bies.202100180 · Cited by 74
A coalition to heal—the impact of the cardiac microenvironment
Tzahor, E., & Dimmeler, S. (2022) · Science · doi:10.1126/science.abm4443 · Cited by 72
Platelet and Erythrocyte Membranes Coassembled Biomimetic Nanoparticles for Heart Failure Treatment
Li, Y., Yu, J., Chen, C., Chen, W., Lin, R., Wang, Y., Cui, W., Meng, J., Du, J., & Wang, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c04814 · Cited by 69
Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis
Cho, S., Rhee, S., Madl, C. M., Caudal, A., Thomas, D., Kim, H., Kojic, A., Shin, H. S., Mahajan, A., Jahng, J. W. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08945-9 · Cited by 75
Liu, X., Burke, R. M., Lighthouse, J. K., Baker, C. D., Dirkx, R. A., Kang, B., Chakraborty, Y., Mickelsen, D. M., Twardowski, J. J., Mello, S. S., et al. (2023) · Circulation Research · doi:10.1161/circresaha.121.320324 · Cited by 65
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Bowers, S., Meng, Q., & Molkentin, J. D. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00043-7 · Cited by 61
MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing
Bugg, D., Bailey, L. R. J., Bretherton, R. C., Beach, K. E., Reichardt, I. M., Robeson, K. Z., Reese, A. C., Gunaje, J. J., Flint, G. V., DeForest, C. A., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.012 · Cited by 57
Yamada, Y., Sadahiro, T., Nakano, K., Honda, S., Abe, Y., Akiyama, T., Fujita, R., Nakamura, M., Maeda, T., Kuze, Y., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067504 · Cited by 58
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 61
Kalyanasundaram, A., Li, N., Gardner, M. L., Artiga, E. J., Hansen, B. J., Webb, A., Freitas, M. A., Pietrzak, M., Whitson, B. A., Mokadam, N. A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051583 · Cited by 51
Fibrosis in Pathology of Heart and Kidney: From Deep RNA-Sequencing to Novel Molecular Targets
Schreibing, F., Anslinger, T. M., & Kramann, R. (2023) · Circulation Research · doi:10.1161/circresaha.122.321761 · Cited by 51
The chromatin landscape of healthy and injured cell types in the human kidney
Gisch, D. L., Brennan, M., Lake, B. B., Basta, J. M., Keller, M. S., Ferreira, R. M., Akilesh, S., Ghag, R. R., Lu, C., Cheng, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44467-6 · Cited by 50
Machine learning approaches to explore digenic inheritance
Okazaki, A., & Ott, J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.04.009 · Cited by 46
Yuan, S., Mu, W., Liu, S., Liu, M., Xia, Z., Liang, S., Gao, T., Fu, S., Liu, J., Huang, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c02272 · Cited by 46
Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells
Fernandes, I. M., Funakoshi, S., Hamidzada, H., Epelman, S., & Keller, G. M. (2023) · Nature Communications · doi:10.1038/s41467-023-43312-0 · Cited by 46
Ke, D., Cao, M., Ni, J., Yuan, Y., Deng, J.-Y., Chen, S., Dai, X., & Zhou, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05353-x · Cited by 46
Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
Shao, J., Liu, J., & Zuo, S. (2022) · Cells · doi:10.3390/cells11152347 · Cited by 41
Genomic enhancers in cardiac development and disease
Anene-Nzelu, C. G., Lee, C. J. M., Tan, W. L. W., Dashi, A., & Foo, R. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00597-2 · Cited by 39
Self-citationAghagolzadeh, P., Plaisance, I., Bernasconi, R., Treibel, T. A., Pulido-Quetglas, C., Wyss, T., Wigger, L., Nemir, M., Sarre, A., Chouvardas, P., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062601 · Cited by 43
Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling
Liu, B., Wang, S., Ma, H., Deng, Y., Du, J., Zhao, Y., & Chen, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05986-y · Cited by 48
Su, D., Jiao, Z., Li, S., Yue, L., Li, C., Deng, M., Hu, L., Dai, L., Gao, B., Wang, J., et al. (2023) · Exploration · doi:10.1002/exp.20220171 · Cited by 36
Xu, X., Hua, X., Han, M., Hu, S., & Song, J. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-022-00972-1 · Cited by 38
Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis
Yang, B., Qiao, Y., Dong, Y., & Meng, Q. (2024) · Cells · doi:10.3390/cells13090764 · Cited by 39
Chelko, S. P., Penna, V. R., Engel, M., Shiel, E. A., Centner, A. M., Farra, W., Cannon, E. N., Landim-Vieira, M., Schaible, N., Lavine, K., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172014 · Cited by 32
Histone H1.0 couples cellular mechanical behaviors to chromatin structure
Hu, S., Chapski, D. J., Gehred, N., Kimball, T. H., Gromova, T., Flores, A., Rowat, A. C., Chen, J., Packard, R. R. S., Olszewski, E., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00460-w · Cited by 32
Self-citationHardy, S. A., Liesinger, L., Patrick, R., Poettler, M., Rech, L., Gindlhuber, J., Mabotuwana, N. S., Ashour, D., Stangl, V., Bigland, M. J., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.010 · Cited by 35
Ailanthone ameliorates pulmonary fibrosis by suppressing JUN-dependent MEOX1 activation
Zhao, L., Zhu, Y., Tao, H., Chen, X., Yin, F., Zhang, Y., Qin, J., Huang, Y., Cai, B., Lin, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.013 · Cited by 32
Self-citationThree-dimensional chromatin organization in cardiac development and disease
Bertero, A., & Rosa‐Garrido, M. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.11.008 · Cited by 32
Zhang, H., Wang, J., Shen, J., Chen, S., Yuan, H., Zhang, X., Liu, X., Yu, Y., Li, X., Gao, Z., et al. (2024) · iMeta · doi:10.1002/imt2.220 · Cited by 31
Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction
Zhang, K., Tao, H., Zhu, D., Yue, Z., Hu, S., Wu, Y., Yan, N., Hu, Y., Liu, S., Liu, M., et al. (2026) · Science · doi:10.1126/science.adu9394 · Cited by 30
Approaches towards tissue‐selective pharmacology of the mineralocorticoid receptor
Clarisse, D., Deng, L., Bosscher, K. D., & Lother, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15719 · Cited by 29
Defining the Fetal Gene Program at Single-Cell Resolution in Pediatric Dilated Cardiomyopathy
Mehdiabadi, N. R., Sim, C. B., Phipson, B., Kalathur, R. K. R., Sun, Y., Vivien, C. J., ter Huurne, M., Piers, A. T., Hudson, J. E., Oshlack, A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057763 · Cited by 29
Immunomodulatory Therapy for Ischemic Heart Disease
Zhao, X., Williamson, T., Gong, Y., Epstein, J. A., & Fan, Y. (2024) · Circulation · doi:10.1161/circulationaha.124.070368 · Cited by 28
Role of Cardiac Fibroblasts in Cardiac Injury and Repair
Han, M., & Zhou, B. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01647-y · Cited by 30
Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
Robinson, E. L., & Port, J. D. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.02.003 · Cited by 29
Zhou, J., Tian, G., Quan, Y., Kong, Q., Huang, F., Li, J., Wu, W.-C., Tang, Y., Zhou, Z., & Liu, X. (2023) · JCI Insight · doi:10.1172/jci.insight.160745 · Cited by 28
Cardiac fibroblasts in myocardial injury and heart failure
Linthout, S. V., Matz, I., González, A., & Davis, J. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf902 · Cited by 38
Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway
Ni, X., Feng, X., Wang, Z., Zhang, Y., Little, P. J., Cao, Y., Xu, S., Tang, L., & Weng, J. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01265-0 · Cited by 27
Przytycki, P. F., & Pollard, K. S. (2021) · Genome biology · doi:10.1186/s13059-021-02279-1 · Cited by 25
Self-citationAll-printed point-of-care immunosensing biochip for one drop blood diagnostics
Chi, J., Wu, Y., Qin, F., Su, M., Cheng, N., Zhang, J., Li, C., Lian, Z., Xu, Y. J., Cheng, L., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00385f · Cited by 25
Dynamic and static biomechanical traits of cardiac fibrosis
Liu, H., Fan, P., Jin, F., Huang, G., Guo, X., & Xu, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1042030 · Cited by 30
Chi, J., Su, M., Xue, B., Cheng, L., Lian, Z., Yang, Y., Xu, Y. J., Wang, X., Xie, H., Wang, H., et al. (2023) · ACS Sensors · doi:10.1021/acssensors.3c00029 · Cited by 24
Chalise, U., & Hale, T. M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00401.2023 · Cited by 25
Nanoscale 3D DNA tracing in single human cells visualizes loop extrusion directly in situPreprint
Beckwith, K. S., Ødegård-Fougner, Ø., Morero, N. R., Barton, C., Schueder, F., Tang, W., Alexander, S., Peters, J., Jungmann, R., Birney, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.12.439407 · Cited by 24
Nguyen, C. D. K., Colón-Emeric, B. A., Murakami, S., Shujath, M. N. Y., & Yi, C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114176 · Cited by 23
Ho, J. S. Y., Jou, E., Khong, P., Foo, R., & Sia, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212010 · Cited by 23
MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis
Schumacher, D., Peisker, F., & Kramann, R. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00842-7 · Cited by 22
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
Ni, X., Zhang, L., Feng, X., & Tang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877797 · Cited by 23
Multiomic Spatial Mapping of Myocardial Infarction and Implications for Personalized Therapy
Schumacher, D., & Kramann, R. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318333 · Cited by 24
Fibroblast Diversity and Epigenetic Regulation in Cardiac Fibrosis
Aguado‐Alvaro, L. P., Garitano, N., & Pelacho, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116004 · Cited by 25
Read, D. F., Booth, G. T., Daza, R. M., Jackson, D. L., Gladden, R. G., Srivatsan, S. R., Ewing, B., Franks, J. M., Spurrell, C. H., Gomes, A. R., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06582-y · Cited by 22
Cold and hot fibrosis define clinically distinct cardiac pathologies
Miyara, S., Adler, M., Umansky, K. B., Häußler, D., Bassat, E., Divinsky, Y., Elkahal, J., Kain, D., Lendengolts, D., Flores, R. O. R., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101198 · Cited by 28
Current and future perspectives of single-cell multi-omics technologies in cardiovascular research
Tan, W. L. W., Seow, W. Q., Zhang, A., Rhee, S., Wong, W. H., Greenleaf, W. J., & Wu, J. C. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00205-7 · Cited by 22
Nishino, T., Ranade, S. S., Pelonero, A., van Soldt, B. J., Ye, L., Alexanian, M., Koback, F. L., Huang, Y., Wallace, L. G., Sadagopan, N., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00367-y · Cited by 19
Self-citationChu, L., Xie, D., & Xu, D. (2023) · Biomolecules · doi:10.3390/biom13091382 · Cited by 19
Yuan, S., Zhang, X., Zhan, J., Xie, R., Fan, J., Dai, B., Zhao, Y., Yin, Z., Liu, Q., Wang, D. W., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2452-2 · Cited by 19
Targeting transcription in heart failure via CDK7/12/13 inhibition
Hsu, A., Duan, Q., Day, D. S., Luo, X., McMahon, S., Huang, Y., Feldman, Z. B., Jiang, Z., Zhang, T., Liang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31541-8 · Cited by 17
Self-citationOrgan fibrosis: beyond collagen I expression. Fibroblast phenotype and basement membrane proteins
Biggs, R. M., & Bradshaw, A. D. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2025 · Cited by 16
Li, G., Qin, Y., Cheng, Z., Cheng, X., Wang, R., Luo, X., Zhao, Y., Zhang, D., & Li, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3235250 · Cited by 17
Hippo-Yap signaling in cardiac and fibrotic remodeling
Re, D. P. D. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100492 · Cited by 17
PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis
Chen, L., Li, H., Liu, X., Zhang, N., Wang, K., Shi, A., Gao, H., Akdiş, D., Saguner, A. M., Xu, X., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01804-5 · Cited by 16
Nichols, A. E. C., Benoodt, L., Adjei-Sowah, E., Jerreld, K., Kollar, A., Ketonis, C., & Loiselle, A. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.526242 · Cited by 16
Liu, C., Rioja, I., Bakr, A., Veldwijk, M. R., Sperk, E., Herskind, C., Weichenhan, D., Prinjha, R. K., Plass, C., Schmezer, P., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33989 · Cited by 17
Jain, R., & Epstein, J. A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_18 · Cited by 16
Self-citationTargeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Amrute, J. M., Luo, X., Penna, V., Bredemeyer, A., Yamawaki, T., Heo, G. S., Shi, S., Koenig, A., Yang, S., Kadyrov, F., et al. (2022) · bioRxiv · doi:10.1101/2022.10.17.512579 · Cited by 14
Targeting macrophage–fibroblast interactions in the failing heart
Frangogiannis, N. G. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01112-z · Cited by 14
Shi, S. Y., Luo, X., Yamawaki, T., Li, C.-M., Ason, B. L., & Furtado, M. B. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01517-z · Cited by 14
The role of MEOX1 in non-neoplastic and neoplastic diseases
Zeng, G., Liu, X., Su, X., Wang, Y.-X., Liu, B., Zhou, H., Wang, Y., & Li, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114068 · Cited by 13
Development of direct cardiac reprogramming for clinical applications
Yamada, Y., Sadahiro, T., & Ieda, M. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.03.002 · Cited by 15
Cohen, C. D., Blasio, M. J. D., Farrugia, G. E., Dona, M. S. I., Hsu, I., Prakoso, D., Kiriazis, H., Krstevski, C., Nash, D. M., Li, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107759 · Cited by 14
Current concepts in the epigenetic regulation of cardiac fibrosis
Hassanabad, A. F., Zarzycki, A. N., Patel, V. B., & Fedak, P. W. M. (2024) · Cardiovascular Pathology · doi:10.1016/j.carpath.2024.107673 · Cited by 16
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure PathogenesisPreprint
Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Lee, C. Y., Sadagopan, N., Huang, Y., Pelonero, A., Auclair, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.522937 · Cited by 14
Self-citationGarvin, A. M., & Katwa, L. C. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00224.2023 · Cited by 15
Schuetze, K. B., Stratton, M. S., Bagchi, R. A., Hobby, A. R. H., Felisbino, M. B., Rubino, M., Toni, L. S., Reges, C. R., Cavasin, M. A., McMahan, R. H., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00438.2024 · Cited by 14
Self-citationAdvances in application of single-cell RNA sequencing in cardiovascular research
Hu, Y., Zhang, Y., Liu, Y., Gao, Y., San, T., Li, X., Song, S., Yan, B., & Zhao, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.905151 · Cited by 13
Ding, S., Zhang, X., Qiu, H., Wo, J., Zhang, F., & Na, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873264 · Cited by 12
Reyat, J. S., Maio, A. D., Grygielska, B., Pike, J. A., Kemble, S., Rodriguez-Romero, A., Karali, C. S., Croft, A. P., Psaila, B., Simões, F. C., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1156759 · Cited by 12
del Cañizo, C. G., Guerrero‐Ramos, F., Pérez-Escavy, M., Lodewijk, I., Suárez-Cabrera, C., Morales, L., Nunes, S. P., Munera-Maravilla, E., Rubio, C., Sánchez‐Domínguez, R., et al. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2438291 · Cited by 12
Advances in Single-Cell Multi-Omics and Application in Cardiovascular Research
Zhang, X., Qiu, H., Zhang, F., & Ding, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.883861 · Cited by 14
Aguado‐Alvaro, L. P., Garitano, N., Esser‐Skala, W., Sayers, J. R., del Valle, C., Alameda, D., Mendieta-Esteban, J., Calleja-Cervantes, M. E., Goñi‐Salaverri, A., Zazpe, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66597-9 · Cited by 13
Metadata
- Authors
- Alexanian, M., Przytycki, P. F., Micheletti, R., Padmanabhan, A., Ye, L., Travers, J. G., Gonzalez-Teran, B., Silva, A. C., Duan, Q., Ranade, S. S., Felix, F., Linares-Saldana, R., Li, L., Lee, C. Y., Sadagopan, N., Pelonero, A., Huang, Y., Andreoletti, G., Jain, R., McKinsey, T. A., Rosenfeld, M. G., Gifford, C. A., Pollard, K. S., Haldar, S. M., & Srivastava, D.
- Affiliations
- Gladstone Institutes (US)
- Howard Hughes Medical Institute (US)
- University of Colorado Anschutz (US)
- University of Pennsylvania (US)
- University of California, San Francisco (US)
- Amgen (United States) (US)
- Corresponding author
- Haldar, Saptarsi M.
- Srivastava, Deepak
- ORCID
- Alexanian, Michael
- Przytycki, Pawel F.
- Micheletti, Rudi
- Padmanabhan, Arun
- Travers, Joshua G.
- Gonzalez-Teran, Barbara
- Silva, Ana Catarina
- Duan, Qiming
- Ranade, Sanjeev S.
- Felix, Franco
- Linares-Saldana, Ricardo
- Li, Li
- Lee, Clara Youngna
- Pelonero, Angelo
- Huang, Yu
- Andreoletti, Gaia
- Jain, Rajan
- McKinsey, Timothy A.
- Gifford, Casey A.
- Pollard, Katherine S.
- Haldar, Saptarsi M.
- Srivastava, Deepak
- Venue
- Nature
- Published
- 2021-06-23
- Volume
- 595
- Issue
- 7867
- Pages
- 438-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8341289
- OpenAlex
- W3176137376
- Cited by
- 238
- References
- 53
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 47 · 2023: 39 · 2022: 45 · 2021: 13
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Science Foundation
- American Heart Association (18POST34080175, 16SFRN31400013)
- A.P. Giannini Foundation (P0527061)
- Tobacco-Related Disease Research Program (578649)
- Gladstone Institutes
- Giannini Foundation of Agricultural Economics (P0527061)
- Roddenberry Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (186704)
- National Institutes of Health (16SFRN31400013, P01 HL098707, 1c06rr018928-01, HL146366, HL098179)
- Agency for Healthcare Research and Quality (R01HS015100)
- National Heart, Lung, and Blood Institute (F32HL147463, R01HL147558, R01HL116848, R01HL139783, P01HL146366, UM1HL098179, R01HL150100, P01HL089707, R01HL127240, R01HL150521, U01HL098179, R01HL150225, R01HL057181, K08HL157700)
- National Institute of Mental Health (R01MH123178)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119594)
- National Center for Research Resources (C06-RR-018928, RR018928)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibroblast activation, cardiac fibroblasts, BET proteins, MEOX1, transcriptional switch, chromatin accessibility, enhancers, TGF-beta signaling, myocardial fibrosis, cardiac dysfunction, fibrotic diseases, BET inhibitors, cis-regulatory elements, single-cell epigenomics
- MeSH terms
- Bromodomain Containing Proteins, Animals, Chromatin, Enhancer Elements, Genetic, Fibroblasts, Gene Expression Regulation, Heart Diseases, Humans, Proteins, Transcription Factors, Transforming Growth Factor beta, Homeodomain Proteins, Mice, Epigenomics, Single-Cell Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
